Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 211-220 of 225 for multiple myeloma

Edit search filters
  1. A study of how current treatments impact the course of relapsed myeloma and the effect of the treatments on the quality-of-life measurements.

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Study to Compare Subcutaneous Daratumumab with Intravenous Daratumumab

    Rochester, MN

  3. Longterm Follow-up of Subjects Treated With bb2121

    Rochester, MN

  4. A Study to Assess Financial Burden and Its Impact on Quality of Life in Patients with Plasma Cell Disorders

    Rochester, MN

  5. Appointment Companion Tool

    Rochester, MN

  6. A Study to Evaluate Gut Microbiome with POEMS Syndrome and Other Plasma Cell Disorders

    Rochester, MN

  7. Symptomatic Assessment in Patients with Chronic Hematologic Malignancies

    Scottsdale/Phoenix, AZ

  8. A Study to Evaluate the Safety, PK/​PD of (OriCAR-017) in Subjects With RR/​MM - RIGEL Study

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Global Cardio Oncology Registry

    Rochester, MN

  10. Low-Dose Selinexor and Choline Salicylate for the Treatment of Patients With Non-Hodgkin Lymphoma or Histiocytic/Dendritic Cell Neoplasms

    Rochester, MN

.

Mayo Clinic Footer